ESG News For CORE CORPORATION

Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that it has published its 2024 Sustainability Report. The report highlights the company’s continued commitment and progress on its key corporate sustainability initiatives. The Sustainability Report can be found on the company’s website here.“I am proud to issue our sixth annual Sustainabili

Highlights corporate responsibility commitment to building more connected, sustainable and resilient communities for future generations

Global food and nutrition leader recognized for its protein innovation

Employee volunteers from Domtar’s Hawesville Pulp & Paper Manufacturing Mill read to Perry Central Elementary students; a grant from Domtar funded 160 books for the school.

Employee volunteers from Domtar’s DuBois Converting Facility read to Wasson Elementary students; a grant from Domtar funded 225 books for the school.